Oncology & Cancer

In first for EU, anti-skin cancer drug approved

French pharmaceutical giant Sanofi on Friday said the European Medicines Agency had conditionally approved its anti-cancer drug Libtayo, the first drug of its kind to be authorised for use in the EU.

Oncology & Cancer

Working to advance radiation therapy for children with cancer

Doctors at Children's Hospital Los Angeles continue to lead the field of radiation oncology by pushing the leading edge of technological advances. A new report by Arthur Olch, Ph.D., highlights use of specialized software ...

Medical research

Old nuclear fallout study provides pancreatic promise

A Rice University chemist's research conducted years ago to protect people from radiation poisoning due to nuclear fallout may now offer a glimmer of hope to patients with pancreatic cancer.

page 3 from 23